| Product Code: ETC6736662 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Arteriovenous Malformations (AVMs) Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, 2021 & 2031F |
3.3 China Arteriovenous Malformations (AVMs) Market - Industry Life Cycle |
3.4 China Arteriovenous Malformations (AVMs) Market - Porter's Five Forces |
3.5 China Arteriovenous Malformations (AVMs) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Arteriovenous Malformations (AVMs) Market Revenues & Volume Share, By Stages, 2021 & 2031F |
3.7 China Arteriovenous Malformations (AVMs) Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 China Arteriovenous Malformations (AVMs) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 China Arteriovenous Malformations (AVMs) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Arteriovenous Malformations (AVMs) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about arteriovenous malformations (AVMs) and advancements in medical technology. |
4.2.2 Growing healthcare infrastructure and investments in China. |
4.2.3 Rising incidences of neurological disorders and vascular diseases in the region. |
4.3 Market Restraints |
4.3.1 High treatment costs associated with AVMs therapies. |
4.3.2 Limited availability of skilled healthcare professionals specializing in AVM treatment. |
4.3.3 Stringent regulatory requirements for the approval and commercialization of AVM treatment options. |
5 China Arteriovenous Malformations (AVMs) Market Trends |
6 China Arteriovenous Malformations (AVMs) Market, By Types |
6.1 China Arteriovenous Malformations (AVMs) Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By True Arteriovenous Malformation, 2021- 2031F |
6.1.4 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Occult or Cryptic, 2021- 2031F |
6.1.5 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Cavernous Malformations, 2021- 2031F |
6.1.6 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Venous Malformation, 2021- 2031F |
6.1.7 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Hemangioma, 2021- 2031F |
6.1.8 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Dural Fistula, 2021- 2031F |
6.2 China Arteriovenous Malformations (AVMs) Market, By Stages |
6.2.1 Overview and Analysis |
6.2.2 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Stage I (Quiescence), 2021- 2031F |
6.2.3 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Stage II (Expansion), 2021- 2031F |
6.2.4 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Stage III (Destruction), 2021- 2031F |
6.2.5 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Stage IV (Decompensation), 2021- 2031F |
6.2.6 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Arteriovenous Malformations (AVMs) Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.3.3 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Medication, 2021- 2031F |
6.3.4 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3.5 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Arteriovenous Malformations (AVMs) Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.4.5 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Others, 2021- 2031F |
6.5 China Arteriovenous Malformations (AVMs) Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.5.3 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.4 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.5 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.6 China Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Others, 2021- 2031F |
7 China Arteriovenous Malformations (AVMs) Market Import-Export Trade Statistics |
7.1 China Arteriovenous Malformations (AVMs) Market Export to Major Countries |
7.2 China Arteriovenous Malformations (AVMs) Market Imports from Major Countries |
8 China Arteriovenous Malformations (AVMs) Market Key Performance Indicators |
8.1 Number of AVM cases diagnosed annually in China. |
8.2 Adoption rate of minimally invasive AVM treatment procedures. |
8.3 Investment in research and development for innovative AVM therapies. |
8.4 Patient satisfaction rate with AVM treatment outcomes. |
8.5 Number of healthcare facilities offering specialized AVM treatment services in China. |
9 China Arteriovenous Malformations (AVMs) Market - Opportunity Assessment |
9.1 China Arteriovenous Malformations (AVMs) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Arteriovenous Malformations (AVMs) Market Opportunity Assessment, By Stages, 2021 & 2031F |
9.3 China Arteriovenous Malformations (AVMs) Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 China Arteriovenous Malformations (AVMs) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 China Arteriovenous Malformations (AVMs) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Arteriovenous Malformations (AVMs) Market - Competitive Landscape |
10.1 China Arteriovenous Malformations (AVMs) Market Revenue Share, By Companies, 2024 |
10.2 China Arteriovenous Malformations (AVMs) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here